SSA
BEAM icon

Schonfeld Strategic Advisors’s Beam Therapeutics BEAM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
+53,722
New +$1.62M 0.01% 1110
2026
Q1 		– Sell
-128,360
Closed -$3.56M – 2232
2025
Q4 		$3.56M Sell
128,360
-167,730
-57% -$4.28M 0.02% 670
2025
Q3 		$7.19M Buy
296,090
+67,228
+29% +$1.34M 0.04% 453
2025
Q2 		$3.89M Buy
+228,862
New +$3.99M 0.03% 658
2025
Q1 		– Sell
-15,531
Closed -$385K – 2207
2024
Q4 		$385K Buy
15,531
+5,514
+55% +$141K ﹤0.01% 1511
2024
Q3 		$245K Sell
10,017
-20,500
-67% -$530K ﹤0.01% 1741
2024
Q2 		$715K Sell
30,517
-18,181
-37% -$447K ﹤0.01% 1347
2024
Q1 		$1.61M Buy
48,698
+23,193
+91% +$723K 0.01% 1058
2023
Q4 		$694K Sell
25,505
-51,567
-67% -$1.28M ﹤0.01% 1170
2023
Q3 		$1.85M Buy
77,072
+2,168
+3% +$58.1K 0.01% 851
2023
Q2 		$2.39M Buy
74,904
+40,839
+120% +$1.33M 0.02% 695
2023
Q1 		$1.04M Buy
34,065
+13,665
+67% +$539K 0.01% 943
2022
Q4 		$798K Buy
20,400
+4,869
+31% +$218K 0.01% 1269
2022
Q3 		$739K Sell
15,531
-42,369
-73% -$2.42M 0.01% 1480
2022
Q2 		$2.24M Buy
+57,900
New +$2.3M 0.02% 712
2022
Q1 		– Sell
-12,260
Closed -$977K – 2591
2021
Q4 		$977K Buy
12,260
+5,952
+94% +$510K 0.01% 955
2021
Q3 		$549K Buy
6,308
+4,308
+215% +$433K 0.01% 1217
2021
Q2 		$257K Buy
+2,000
New +$159K ﹤0.01% 1542

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Schonfeld Strategic Advisors's BEAM Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 53,722 shares worth $1.84M. The stake represents 0.01% of the portfolio and ranks #1110 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in BEAM as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in BEAM in Q2 2021 and has held it in 18 quarters since. The position peaked at $7.19M in Q3 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Schonfeld Strategic Advisors held 53,722 shares of Beam Therapeutics worth $1.84M as of Q2 2026.
  • Beam Therapeutics was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Beam Therapeutics made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1110 holding.
  • Schonfeld Strategic Advisors first reported a position in Beam Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Schonfeld Strategic Advisors's Beam Therapeutics position peaked at $7.19M in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.